Search results for: 'effectiveness ad models for compon'

The pharmaceutical (pharma) industry is undergoing significant regulatory changes resulting from the European Green Deal and the Paris Agreement. These changes require pharma companies to adopt more environmentally sustainable practices. With the increasing demand for drugs globally, pharma R&D and manufacturing infrastructure has grown, leading to...

Healthcare as an industry is entering a phase of rapid transformation. Institutions across the stakeholder spectrum including health insurers, providers, and therapeutic developers face the proposition of adapt or collapse. The health insurance industry particularly is evaluating all aspects of its business models, policy holder engagement, and pla...

Traditional training environments face patient safety risks, resource constraints, and limited exposure to rare event scenarios. Additionally, physical simulations are costly, limiting accessibility (especially in resource-constrained settings). Current simulation models lack personalization, resulting in operational complexity for hospitals due to...

This study provides insights across recent advances across the use of animal disease models in preclinical research.It encompasses the following aspects: Technology roadmap, market trends, capabilities, and targeted application Stakeholder activities, influence, industry initiatives Investment environment and funding support Industry evolution and ...

Hospital at Home is an innovative care model for healthcare organizations to provide hospital-level care in home for patients who meet acute inpatient admission requirements. CMS states that under this model, the patient home is considered part of the hospital during the tenure of care. The study provides a detailed understanding of the hospital at...

The key focus of this research has been outlined as below: 1. Technology benchmarking and roadmap, market trends, capabilities, and applications targeted: Build a robust strategy by defining the universe of preclinical disease models opportunities and setting key priorities 2. Stakeholder activities, influence, industry initiatives: Evaluate opport...

This study focuses on emerging pharmacological and non-pharmacological strategies in the treatment of obesity, as well as evolving new paradigms for the future. It describes the contribution of incretin-based therapies, particularly GLP-1 receptor agonists and their multi-agonist counterparts, which provide robust effects on weight loss and metabol...

29 Mar 2021  |  Global  |  Market Research

Data Monetization Drives Innovative Business Models in the Global MedTech Industry

Data-Enabled Growth Strategies Counterbalance Competitive Intensity

Infographics

×

Key Issues Addressed

With the advent of digitization in healthcare, all industry efforts are geared toward better leveraging this stream of digital data to achieve the goals of precision medicine and precision health. The amount of health data that is becoming available is increasing exponentially each year, with new sources, such as wearable devices and social determi...

The healthcare landscape is experiencing a profound shift as it shifts away from traditional fee-for-service models toward value-based care. This transition emphasizes collaboration among healthcare stakeholders, fostering a patient-centric approach. The focus is not merely on the quantity of services delivered but also on the quality of care, enco...